Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Gains from Investment Securities (2019 - 2025)

Historic Gains from Investment Securities for IDEAYA Biosciences (IDYA) over the last 7 years, with Q1 2025 value amounting to $6.2 million.

  • IDEAYA Biosciences' Gains from Investment Securities fell 5733.79% to $6.2 million in Q1 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 8201.85%. This contributed to the annual value of $32.0 million for FY2024, which is 8934.91% up from last year.
  • As of Q1 2025, IDEAYA Biosciences' Gains from Investment Securities stood at $6.2 million, which was down 5733.79% from $1.6 million recorded in Q4 2024.
  • IDEAYA Biosciences' 5-year Gains from Investment Securities high stood at $14.5 million for Q1 2024, and its period low was -$2.4 million during Q4 2021.
  • For the 5-year period, IDEAYA Biosciences' Gains from Investment Securities averaged around $3.3 million, with its median value being $1.3 million (2023).
  • Examining YoY changes over the last 5 years, IDEAYA Biosciences' Gains from Investment Securities showed a top increase of 1510000.0% in 2021 and a maximum decrease of 104641.15% in 2021.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Gains from Investment Securities stood at -$2.4 million in 2021, then soared by 125.04% to $600000.0 in 2022, then surged by 2050.0% to $12.9 million in 2023, then tumbled by 87.6% to $1.6 million in 2024, then skyrocketed by 286.62% to $6.2 million in 2025.
  • Its Gains from Investment Securities stands at $6.2 million for Q1 2025, versus $1.6 million for Q4 2024 and $3.4 million for Q3 2024.